Chemotherapy of advanced neuroblastoma: does adriamycin contribute?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
A proposed staging for children with neuroblastoma.Children's cancer study group A
1971 • 967 citations
Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer
1975 • 398 citations
Statistical estimation of prognosis for children with neuroblastoma.
1971 • 321 citations
The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children
1974 • 235 citations
Neuroblastoma, Its Natural History and Prognosis: A Study of 487 Cases
1974 • 232 citations
Clinical trials with adriamycin
1971 • 229 citations
Neuroblastoma: Review of the literature and an examination of factors contributing to its enigmatic character
1976 • 150 citations
Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study group
1979 • 142 citations
International Symposium on Adriamycin
1972 • 123 citations
Clinical Trials with Adriamycin. Results of Three-Years Study
1972 • 66 citations
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
1979 • 61 citations
Cis‐diamminedichloroplatinum (NSC‐119875) in childhood malignancies: A southwest oncology group study
1978 • 59 citations
Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma.
1977 • 57 citations
Vincristine Sulfate and Cyclophosphamide for Children With Metastatic Neuroblastoma
1969 • 44 citations
The impact of chemotherapy on advanced neuroblastoma. Survival of patients diagnosed in 1956, 1962, and 1966–68 in Children's Cancer Study Group A
1974 • 44 citations
Effect of vincristine (NSC-67574) on malignant solid tumors in children.
1968 • 29 citations
Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
1977 • 19 citations
Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
1974 • 18 citations